
Dec 9 (Reuters) - CVS Health (CVS) on Tuesday forecast 2026 profit above Wall Street estimates and this year's projected earnings, signalling steady progress in the health conglomerate's turnaround plan.
CVS stock rose 5% in early trading on Tuesday.
The company in October projected double-digit earnings growth for 2026 after raising its 2025 profit forecast for the third time.
"We are closing out 2025 with meaningful momentum across our businesses and we expect another year of strong earnings growth in 2026," said Chief Financial Officer Brian Newman on Tuesday.
The company forecast 2026 adjusted profit to be in the range of $7.00 to $7.20 per share, compared with analysts' average estimate of $7.16, according to data compiled by LSEG.
It, however, expects total revenue of at least $400 billion next year, below analysts' average estimate of $419.26 billion.
CVS also raised its 2025 adjusted profit forecast to $6.60 to $6.70 per share from $6.55 to $6.65 previously.
(Reporting by Sneha S K in Bengaluru; Editing by Shinjini Ganguli)
LATEST POSTS
- 1
Director of Swiss hospital describes the rush to treat the injured from Alpine resort bar fire - 2
Illumina unveils dataset to speed up AI-powered drug discovery - 3
Instructions to Pick the Ideal SUV Size for Seniors - 4
South African army arrive in crime hotspots to help tackle gangs - 5
Audits of 6 European Busssiness Class Flights
NASA releases stunning first images of Earth taken by the Artemis II astronauts
Vote in favor of the bloom plan that adds a bit of excellence to your life!
Day to day Temporary Positions That Compensate Fairly in the US
'An incredible privilege and responsibility': Artemis 2's Christina Koch is ready to become the 1st woman to fly around the moon
Aspect Biosystems receives funding for cellular medicine project
Freed whale gets stranded again off German coast
After fleeing past Hezbollah fighting, some Israelis on northern border vow to stay
Manual for Tracking down Spending plan Agreeable Travel Objections
The Electric Bicycle Americans Can Confide in 2024













